Europe Cell Therapy Market Business Revenue Forecast and Statistics, Growth Prospective (2019-2027)

The Europe Cell therapy market is expected to reach US$ 3,610.7 million by 2027 from US$ 2,125.7 million in 2019; it is anticipated to grow at a CAGR of 6.9% during 2019–2027. 

Market Introduction

Administering living, intact cells into a patient's body via injection, implantation, or grafting is the essence of cell therapy. This medical technology operates on the principle of replacing malfunctioning cells with healthy, functional ones. Stem cells are pivotal in these advanced therapies due to their capacity to differentiate into the specific cell types required for the repair of damaged or defective tissues or cells. Furthermore, cell therapy is integral to the progress of regenerative medicine. The anticipated expansion of the Cell therapy market during the forecast period is likely to be fueled by the increasing occurrence of chronic diseases, the
growing adoption of regenerative medicine, and a rising number of approved cell-based therapies.

Download our Sample PDF Report

@ https://www.businessmarketinsights.com/sample/TIPRE00019052

Market Dynamics

The future growth of the Cell therapy market is expected to be propelled by factors such as the increasing prevalence of chronic diseases, the expanding utilization of regenerative medicine, and the rising number of
approvals for cell-based treatments. However, a potential challenge that could impact the market during the forecast period is the high cost associated with the production of cell therapies, particularly in developing nations.

The COVID-19 pandemic presented a considerable obstacle across the European region. The cell therapy instrument market faced initial setbacks at the beginning of the crisis due to disruptions in supply networks
and a decline in demand caused by widespread lockdowns imposed by many European countries. However, subsequent government actions and support led to a significant increase in the need for cell therapy.

Market Scope

The scope of the European Cell therapy market encompasses therapy type, product, technology, application, end user, and country. With respect to therapy types, the allogeneic segment held the largest market share in 2019, primarily owing to the considerable availability of approved products for clinical use. However, the autologous segment is also anticipated to demonstrate the highest CAGR within the market during the forecast period.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the Europe Cell therapy market report are the World Health Organization (WHO), European Centre for Disease Prevention and Control (ECDC), Alliance for Regenerative Medicine, National Institutes of Health, Anthony Nolan Foundation, among others.

EUROPE CELL THERAPY MARKET SEGMENTATION

Europe Cell Therapy Market: By Therapy Type

• Allogeneic


• Autologous

Europe Cell Therapy Market:  By Product

• Consumables


• Equipment


• Systems and Software

Europe Cell Therapy Market: By Technology

• Viral Vector Technology


• Genome Editing Technology


• Somatic Cell Technology


• Cell Immortalization Technology


• Cell Plasticity Technology


• Three-Dimensional Technology

Europe Cell Therapy Market: By Application

• Oncology


• Cardiovascular


• Orthopedic


• Wound Management


• Other Applications

 Europe Cell Therapy Market: By End User

• Research Institutes


• Hospitals


• Others

 Europe Cell Therapy Market: By Country

• Germany


• France


• Italy


• UK


• Spain

 Europe Cell Therapy Market: Company Profiles

• Vericel Corporation


• MEDIPOST


• NuVasive, Inc.


• Mesoblast Limited


• Smith & Nephew


• Bristol-Myers Squibb Company


• Cells for Cells

About Us:

Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics &
Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, &
Telecommunications